{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:14:05Z","timestamp":1791951245971,"version":"4.3.4"},"reference-count":41,"publisher":"National Academy of Sciences","issue":"39","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"HHS | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R37 NS36193"],"award-info":[{"award-number":["R37 NS36193"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"HHS | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01AG051490"],"award-info":[{"award-number":["1R01AG051490"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"HHS | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["5 U19NS107616"],"award-info":[{"award-number":["5 U19NS107616"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR-19.13"],"award-info":[{"award-number":["W.OR-19.13"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018748","name":"Argenx","doi-asserted-by":"publisher","award":["no number"],"award-info":[{"award-number":["no number"]}],"id":[{"id":"10.13039\/100018748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2024,9,24]]},"abstract":"<jats:p>Myasthenia gravis (MG) is a chronic and severe disease of the skeletal neuromuscular junction (NMJ) in which the effects of neurotransmitters are attenuated, leading to muscle weakness. In the most common forms of autoimmune MG, antibodies attack components of the postsynaptic membrane, including the acetylcholine receptor (AChR) or muscle-specific kinase (MuSK). MuSK, a master regulator of NMJ development, associates with the low-density lipoprotein-related receptor 4 (Lrp4) to form the signaling receptor for neuronal Agrin, a nerve-derived synaptic organizer. Pathogenic antibodies to MuSK interfere with binding between MuSK and Lrp4, inhibiting the differentiation and maintenance of the NMJ. MuSK MG can be debilitating and refractory to treatments that are effective for AChR MG. We show here that recombinant antibodies, derived from MuSK MG patients, cause severe neuromuscular disease in mice. The disease can be prevented by a MuSK agonist antibody, presented either prophylactically or after disease onset. These findings suggest a therapeutic alternative to generalized immunosuppression for treating MuSK MG by selectively and directly targeting the disease mechanism.<\/jats:p>","DOI":"10.1073\/pnas.2408324121","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T13:40:03Z","timestamp":1726580403000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":24,"title":["Agonist antibody to MuSK protects mice from MuSK myasthenia gravis"],"prefix":"10.1073","volume":"121","author":[{"given":"Julien","family":"Oury","sequence":"first","affiliation":[{"name":"Helen L. and Martin S. Kimmel Center for Biology and Medicine at the Skirball Institute, New York University Medical School, New York, NY 10016"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begona","family":"Gamallo-Lana","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Physiology, Neuroscience Institute, New York University School of Medicine, New York, NY 10016"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Santana","sequence":"additional","affiliation":[{"name":"Helen L. and Martin S. Kimmel Center for Biology and Medicine at the Skirball Institute, New York University Medical School, New York, NY 10016"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Steyaert","sequence":"additional","affiliation":[{"name":"argenx, Zwijnaarde 9052, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7268-9818","authenticated-orcid":false,"given":"Dana L. E.","family":"Vergoossen","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Leiden University Medical Centre, Leiden 2300 RC, The Netherlands"},{"name":"Department of Neurology, Leiden University Medical Centre, Leiden 2300 RC, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Mar","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Physiology, Neuroscience Institute, New York University School of Medicine, New York, NY 10016"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9352-3933","authenticated-orcid":false,"given":"Bernhardt","family":"Vankerckhoven","sequence":"additional","affiliation":[{"name":"argenx, Zwijnaarde 9052, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Silence","sequence":"additional","affiliation":[{"name":"argenx, Zwijnaarde 9052, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0829-6128","authenticated-orcid":false,"given":"Roeland","family":"Vanhauwaert","sequence":"additional","affiliation":[{"name":"argenx, Zwijnaarde 9052, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6082-5042","authenticated-orcid":false,"given":"Maartje G.","family":"Huijbers","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Leiden University Medical Centre, Leiden 2300 RC, The Netherlands"},{"name":"Department of Neurology, Leiden University Medical Centre, Leiden 2300 RC, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3550-6891","authenticated-orcid":false,"given":"Steven J.","family":"Burden","sequence":"additional","affiliation":[{"name":"Helen L. and Martin S. Kimmel Center for Biology and Medicine at the Skirball Institute, New York University Medical School, New York, NY 10016"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.2.133"},{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00033.2014"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/35097557"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.7.2895"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81251-9"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81252-0"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1242\/dev.02696"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.10.002"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.10.006"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.279307"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009167"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11348"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70201-7"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13592"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/85520"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fnmol.2020.00159","article-title":"Myasthenia Gravis with antibodies against muscle specific kinase: An update on clinical features, pathophysiology and treatment","volume":"13","author":"Cao M.","year":"2020","unstructured":"M. Cao, I. Koneczny, A. Vincent, Myasthenia Gravis with antibodies against muscle specific kinase: An update on clinical features, pathophysiology and treatment. Front. Mol. Neurosci. 13, 159 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00357-4"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13518"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2006.09.019"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1313944110"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080695"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1007\/s00415-021-10603-9","article-title":"MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation","volume":"268","author":"Konig N.","year":"2021","unstructured":"N. Konig , MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation. J. Neurol. 268, 4824\u20134833 (2021).","journal-title":"J. Neurol."},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0079-y"},{"key":"e_1_3_4_24_2","first-page":"1","article-title":"Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis","volume":"118","author":"Vergoossen D. L. E.","year":"2021","unstructured":"D. L. E. Vergoossen , Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis. Proc. Natl. Acad. Sci. U.S.A. 118, 1\u20139 (2021).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws025"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13543"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000547"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03672-3"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","unstructured":"R. Vanhauwaert ARGX-119 a therapeutic agonist antibody targeting MuSK. bioRxiv [Preprint] (2024). https:\/\/doi.org\/10.1101\/2024.07.18.604166 (Accessed 22 July 2024).","DOI":"10.1101\/2024.07.18.604166"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.279745.116"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1523\/JNEUROSCI.3381-14.2015","article-title":"MuSK frizzled-like domain is critical for mammalian neuromuscular junction formation and maintenance","volume":"35","author":"Messeant J.","year":"2015","unstructured":"J. Messeant , MuSK frizzled-like domain is critical for mammalian neuromuscular junction formation and maintenance. J. Neurosci. 35, 4926\u20134941 (2015).","journal-title":"J. Neurosci."},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.12.025"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34375","article-title":"Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody","volume":"7","author":"Cantor S.","year":"2018","unstructured":"S. Cantor , Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody. Elife 7 (2018).","journal-title":"Elife"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.12.002"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.24.12161-12168.2001"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2012.09.001"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20200513","article-title":"Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis","volume":"217","author":"Fichtner M. L.","year":"2020","unstructured":"M. L. Fichtner , Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis. J. Exp. Med. 217, 1\u201313 (2020).","journal-title":"J. Exp. Med."},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s40478-022-01454-0","article-title":"Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy","volume":"10","author":"Fichtner M. L.","year":"2022","unstructured":"M. L. Fichtner , Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy. Acta Neuropathol. Commun. 10, 154 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.1250744","article-title":"Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction","volume":"345","author":"Arimura S.","year":"2014","unstructured":"S. Arimura , Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction. Science 345, 1505\u20131508 (2014).","journal-title":"Science"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201607298"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2012.08.004"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.2408324121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T13:40:08Z","timestamp":1726580408000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/10.1073\/pnas.2408324121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":41,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2024,9,24]]}},"alternative-id":["10.1073\/pnas.2408324121"],"URL":"https:\/\/doi.org\/10.1073\/pnas.2408324121","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"2024-04-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2408324121"}}